Cargando…

Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments

BACKGROUND: Current radiological assessments of (18)fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging data in diffuse large B-cell lymphoma (DLBCL) can be time consuming, do not yield real-time information regarding disease burden and organ involvement, and hinder the use of FDG-PET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jemaa, S., Paulson, J. N., Hutchings, M., Kostakoglu, L., Trotman, J., Tracy, S., de Crespigny, A., Carano, R. A. D., El-Galaly, T. C., Nielsen, T. G., Bengtsson, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373298/ https://www.ncbi.nlm.nih.gov/pubmed/35962459 http://dx.doi.org/10.1186/s40644-022-00476-0

Ejemplares similares

Heart and bladder detection and segmentation on FDG PET/CT by deep learning
por: Wang, Xiaoyong, et al.
Publicado: (2022)

Tumor Segmentation and Feature Extraction from Whole-Body FDG-PET/CT Using Cascaded 2D and 3D Convolutional Neural Networks
por: Jemaa, Skander, et al.
Publicado: (2020)

P1244: AN AUTOMATED QUANTIFICATION ALGORITHM FOR EVALUATING TOTAL METABOLIC TUMOR VOLUME IN PATIENTS WITH FDG-AVID LYMPHOMAS USING A DEEP LEARNING MODEL
por: Xu, Tao, et al.
Publicado: (2023)

Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
por: Mikhaeel, N. George, et al.
Publicado: (2016)

New Approaches in Characterization of Lesions Dissemination in DLBCL Patients on Baseline PET/CT
por: Cottereau, Anne-Ségolène, et al.
Publicado: (2021)

Prognostic value of the baseline 18F-FDG PET/CT metabolic tumour volume (MTV) and further stratification in low-intermediate (L-I) and high-intermediate (H-I) risk NCCNIPI subgroup by MTV in DLBCL MTV predict prognosis in DLBCL
por: Zhao, Peng, et al.
Publicado: (2020)

Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
por: Mazzara, Saveria, et al.
Publicado: (2022)

Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients
por: Weisman, Amy J., et al.
Publicado: (2020)

Prognostic Impact of Pretreatment 2-[(18)F]-FDG PET/CT Parameters in Primary Gastric DLBCL
por: Albano, Domenico, et al.
Publicado: (2021)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

The use of FDG-PET in diffuse large B cell lymphoma (DLBCL): predicting outcome following first line therapy
por: Coughlan, Monica, et al.
Publicado: (2014)

Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
por: Eertink, Jakoba J., et al.
Publicado: (2022)

Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT
por: Niyazi, Maximilian, et al.
Publicado: (2013)

Recurrent PET FDG Uptake after Sequential Chemotherapy and Radiation Therapy for DLBCL of the Tibia: A Case Report and Review of the Literature
por: Miles, Edward F., et al.
Publicado: (2011)

Automated Identification of Dementia Using FDG-PET Imaging
por: Xia, Yong, et al.
Publicado: (2014)

Progression Free Survival and Predictor of Recurrence in DLBCL patients with Negative Interim (18)FDG PET/CT Using Standardized Imaging and Reporting Protocols
por: Zaman, Maseeh uz, et al.
Publicado: (2020)

PET-CT Imaging of Lymphoma
por: Kostakoglu, Lale
Publicado: (2010)

Prognostic value of baseline total metabolic tumour volume of (18)F-FDG PET/CT imaging in patients with angioimmunoblastic T-cell lymphoma
por: Gong, Huanyu, et al.
Publicado: (2021)

(18)F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
por: Girum, Kibrom B., et al.
Publicado: (2022)

FDG-PET/CT based response-adapted treatment
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2012)

Clinical value of baseline (18)F-FDG PET/CT in soft tissue sarcomas
por: Reyes Marlés, Rafael Hernando, et al.
Publicado: (2021)

Partial volume correction strategies for quantitative FDG PET in oncology
por: Hoetjes, Nikie J., et al.
Publicado: (2010)

The Immunology of DLBCL
por: Takahara, Taishi, et al.
Publicado: (2023)

Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT
por: Kirienko, Margarita, et al.
Publicado: (2018)

Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)

Diagnostic value of baseline (18)FDG PET/CT skeletal textural features in follicular lymphoma
por: Faudemer, Julie, et al.
Publicado: (2021)

The impact of baseline (18)F-FDG PET-CT on the management and outcome of patients with gastric cancer
por: Foley, Kieran G, et al.
Publicado: (2022)

Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma
por: Kanoun, Salim, et al.
Publicado: (2015)

Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on (18)F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma
por: Feng, Xiaoyan, et al.
Publicado: (2021)

Automated differential diagnosis of dementia syndromes using FDG PET and machine learning
por: Perovnik, Matej, et al.
Publicado: (2022)

Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis
por: Cheebsumon, Patsuree, et al.
Publicado: (2011)

Deformation-based morphometry identifies deep brain structures protected by ocrelizumab
por: Song, Zhuang, et al.
Publicado: (2022)

Use of baseline 18F-FDG PET scan to identify initial sub-volumes with local failure after concomitant radio-chemotherapy in head and neck cancer
por: Legot, Floriane, et al.
Publicado: (2018)

Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on (18)F-FDG PET-CT in Patients with Follicular Lymphoma
por: Liang, Jin-Hua, et al.
Publicado: (2019)

Automated macrophage counting in DLBCL tissue samples: a ROF filter based approach
por: Wagner, Marcus, et al.
Publicado: (2019)

FDG-PET in juvenile systemic lupus erythematosus
por: Alberdi, M, et al.
Publicado: (2011)

Predictive Value of Interim PET/CT in DLBCL Treated with R-CHOP: Meta-Analysis
por: Sun, Na, et al.
Publicado: (2015)

Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements
por: Eertink, J. J., et al.
Publicado: (2021)

The Incremental Prognostic Value of Baseline (18)F-FDG PET/CT Imaging in Angioimmunoblastic T-Cell Lymphoma
por: Wang, Hui, et al.
Publicado: (2020)

When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma
por: Hack, Ruben I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sfh4bj5d09chmgmvtmf8mcvu5p